Navigation Links
Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia
Date:1/14/2009

product of a unique clinical development program, one that considered a patient to be a responder to therapy only if they demonstrated concurrent clinically significant changes in multiple aspects of their fibromyalgia, including pain, patient global assessment and physical function. Savella is the only product approved for the management of fibromyalgia that used this complete responder analysis as its primary endpoint," said Jay D. Kranzler, MD, PhD, Chairman and CEO of Cypress Bioscience.

Howard Solomon, Chairman and Chief Executive Officer of Forest said, "We and our partner Cypress Bioscience are very pleased to receive marketing approval for Savella, following a first-cycle review, from the FDA. Fibromyalgia is a chronic and often debilitating condition with a significant need for new therapies. Savella is a valuable new treatment for patients afflicted with fibromyalgia. Its effectiveness was evaluated based upon the multiple symptoms included in the responder analysis."

"This approval is crucial for Pierre Fabre Laboratories as milnacipran is one of the flagship products of our portfolio and represents another product of Pierre Fabre research registered in the United States," said Jean-Pierre Garnier, Chief Executive Officer of Pierre Fabre SA.

Although the exact mechanism by which Savella improves the symptoms of fibromyalgia is unknown, some researchers believe that abnormalities in certain brain neurotransmitters may be central to fibromyalgia. Savella blocks the reuptake of both norepinephrine and serotonin, with greater selectivity for the inhibition of norepinephrine reuptake in vitro. This may be the mechanism by which Savella acts to improve the symptoms of fibromyalgia.

Data Highlights

The clinical development program for Savella was unique in its use of a composite responder analysis as the primary endpoint. This endpoint required individual patients to demonstrate c
'/>"/>

SOURCE Forest Laboratories, Inc.; Cypress Bioscience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Third Quarter Earnings
2. Forest Laboratories Announces Executive Exercised Stock Options With Intent to Hold Shares
3. Forest Laboratories Responds To Unsolicited Mini-Tender Offer
4. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
5. Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
6. Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination
7. Lake Forest, CA: SpeechPhone Launches Handsfree Driving Solution Just in Time to Comply with New Handsfree Driving Laws
8. Wake Forest Class Taps Recordant for Web-Based Search and Playback of Course Materials
9. Cleaner Air May Threaten Amazon Rainforest
10. Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
11. Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Mike Day, ... in 2007, will compete in the Ironman World Championships in Kona on October 10th. ... have incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that restore ...
(Date:9/4/2015)... ... 04, 2015 , ... The conference program for the upcoming ... 9-10, 2015 at the Diplomat Resort & Spa has been announced and is ... at the top of their field and will be presenting sessions such as ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... 2015 , ... EMED Jamaica Global Ltd. (EMED), Jamaica’s premier ... into a multi-year agreement with Health City Cayman Islands. , ( http://www.healthcitycaymanislands.com ) ... healthcare, Jamaican healthcare and Health City Cayman Islands to deliver high-quality, affordable healthcare ...
(Date:9/3/2015)... ... 2015 , ... Allied Anesthesia is proud to announce a continuing partnership with ... exception. , St. Jude was recently named one of the nation’s top stroke centers ... of only 10 hospitals in the state to earn the distinction. , The ...
Breaking Medicine News(10 mins):Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... or Relenza, according to CDC , TUESDAY, Sept. 8 ... which are effective in treating the H1N1 swine flu, should ... those at high risk for complications from the disease, U.S. ... with underlying health conditions, such as asthma or diabetes, as ...
... , OAKLAND, Calif., Sept. 8 (Nasdaq: ... on August 31, 2009, the Company received a NASDAQ Staff Deficiency ... Listing Rule 5550(a)(4). This rule requires the Company to maintain ... the NASDAQ Capital Market. Subsequently on September 4, 2009, the Company ...
... MOUNTAIN VIEW, Calif., Sept. 8 VIVUS, Inc. (Nasdaq: ... and commercialization of novel therapeutic products, plans to announce the results ... on September 9th prior to market open. The announcement will ... Eastern time. , , Conference Call Information ...
... AUSTIN, Texas, Sept. 8 Organix-South, a manufacturer of ... Council,s (ABC) Adopt-an-Herb program by adopting ... will provide ABC with financial support to ensure that summaries ... ( Azadirachta indica ) are made available within ABC,s HerbMedPro ...
... , Expanding facility will provide training ... the Highbridge area of the Bronx , , ... officially open the newest addition to the non-profit agency on September ... cutting ceremony at the facility. Located at 1438 Ogden Ave., ...
... , INDIANAPOLIS, Sept. 8 WellPoint, Inc. (NYSE: ... to present at the 2009 Morgan Stanley Global Healthcare Unplugged Conference ... All interested parties are invited to listen to the webcast ... selecting the "Investor Info" link. Following the presentation, a webcast replay ...
Cached Medicine News:Health News:Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says 2Health News:Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says 3Health News:NASDAQ Stock Market Confirms WorldHeart's Compliance with NASDAQ Listing Rule 5550(a)(4) 2Health News:VIVUS to Host Conference Call and Webcast Discussion of Qnexa Phase 3 Results 2Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 2Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 3Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 4Health News:Highbridge Community Life Center Grand Opening and Ribbon Cutting Ceremony for New Health Careers/Education Facility in the Bronx 2Health News:WellPoint Announces Appearance at Upcoming Conference 2
(Date:9/4/2015)... 4, 2015  Cumberland Pharmaceuticals (CPIX), today announced that ... at VirtualInvestorConferences.com on September 10, 2015. DATE: ... LINK: http://tinyurl.com/sep10pre This will ... invited to ask the company questions in real-time - ... association,s "virtual trade booth." If attendees are not able ...
(Date:9/4/2015)... September 4, 2015 Future Prospects ... Allergic Rhinitis drugs - new study ... Where is the market for allergic rhinitis drugs heading? ... Visiongain ,s new report shows you potential revenues and ... Our 326 page report provides 273 tables, ...
(Date:9/4/2015)... Research and Markets ... the "Veterinary Pharmaceutical Submissions in the EU ... to their offering. This practical two-day ... constituent parts of the application for marketing authorisation ... marketing authorisation is sought in the European Union, ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
... MADISON, N.J., Aug. 12, 2011 Quest Diagnostics ... of diagnostic testing, information and services, today announced that its ... per share, payable on October 24, 2011, to shareholders of record ... About Quest Diagnostics Quest Diagnostics ...
... HeartWare International, Inc. (NASDAQ: HTWR ; ASX: ... support technologies that are revolutionizing the treatment of advanced ... scheduled to make an investor presentation at the Wedbush ... a.m. Eastern Time on Wednesday, August 17, 2011.  The ...
Cached Medicine Technology:HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference 2
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscopes....
... LMA™ Airway., ,Launched in 1988, this ... is now standard practice in general anesthesia. ... the LMA Classic™ is a safe hands ... ,The LMA Classic™ can be used for ...
Medicine Products: